Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe

Search Workers' Comprehensive Articles

  • Reset

November 2022

Medmonitor
Wave of Generic Approvals That Impact Workers’ Comp

First-time generics are available for drugs that treat COPD, HIV, hypertension, and more.

Read More →
This Month's Must Read
Coming Up Short: IT Talent Woes in Workers’ Comp

The insurance sector continues to face IT talent shortages – how does this impact workers’ comp organizations?

Read More →
Clinical Developments
CDC Publishes Updated Opioid Guidelines

An update to the 2016 guidelines has been issued, promoting greater flexibility for individualized patient-centered care.

Read More →
Legislation & Policy
Midterm Marijuana Legalization

Maryland and Missouri voters pass recreational legalization.

Read More →
Industry Trends
WCRI Publishes 23rd Edition of CompScope Medical Benchmarks

Data insights on medical payments for 18 state workers’ comp systems.

Read More →
Workforce Trends
Inflation’s Impact on Workers’ Comp

A series of reports from NCCI examine how medical costs and workforce demographics are changing.

Read More →

October 2022

Medmonitor
FDA Advises Against NSAID Use in Pregnant Women at 20 Weeks and Later

The potential for low amniotic fluid can cause significant health issues.

Read More →
This Month's Must Read
Things Change: The Growing Diversity of Pharmacy Cost Drivers

Smaller, more niche drug trends across different populations and geographies

Read More →
Industry Trends
COVID-19 Workplace Lessons for Employers

The National Safety Council provides information on mental health, workplace safety, and more.

Read More →
COVID-19 Developments
FDA Warns That Certain COVID-19 Variants are Not Neutralized by Evusheld

The only pre-exposure prophylactic for COVID-19 may not provide protection for certain variants.

Read More →
Healthe Developments
3 Tips for Tackling Technology Projects Amid IT Talent Shortage

Healthe’s Chief Information Officer, Brett Luna, speaks to Risk & Insurance® Magazine about this trending topic.

Read More →

September 2022

Medmonitor
Auvelity Approved for Major Depressive Disorder

This antidepressant can yield results as soon as one week, which could generate popularity.

Read More →
This Month's Must Read
Social Influencers: The Role of Social Determinants of Health in Injured Worker Recovery

Gaining visibility into Social Determinants of Health that intersect with workplace injury and recovery.

Read More →
Clinical Insights
A Primer on Behavioral Health Care in Workers’ Compensation

A new report from the WCRI addressed psychosocial barriers to recovery and intervention strategies.

Read More →
COVID-19 Developments
FDA Authorizes Additional Round of COVID-19 Boosters

Moderna and Pfizer boosters have been updated to target the omicron variant.

Read More →
Healthe Developments
Connect with Healthe at National Comp 2022!

Stop by our educational session or visit our booth to take part in our industry survey.

Read More →

August 2022

Medmonitor
FDA Authorizes New COVID-19 Vaccine

Novavax COVID-19 Vaccine, Adjuvanted will require two doses given three weeks apart.

Read More →
This Month's Must Read
In Harm’s Way: The Impact of Violence in Workers’ Comp

How different forms of violence can be detrimental to worker performance and recovery.

Read More →
Clinical Insights
Comparing Cannabis-Based Products for Chronic Pain

A systematic review from the Annals of Internal Medicine evaluates different cannabis formulations.

Read More →
Legislation & Policy
Federal Bill Could Settle Worker Classification Debate for Gig Workers

If enacted, this bill would create an exemption where gig workers do not receive employee benefits.

Read More →
Healthe Developments
Healthe Leader Discusses Talent Troubles in Workers’ Comp

Stephanie Arkelian dives into the issue with Risk & Insurance® magazine, and an upcoming presentation at the Georgia Board of Workers’ Compensation Annual Educational Conference.

Read More →

July 2022

Medmonitor
FDA Recalls Morphine Sulfate ER Due to Potentially Deadly Label Mix-Up

A mix-up between 30 mg and 60 mg tablets could cause severe adverse events.

Read More →
This Month's Must Read
The Cannabis Question: Marijuana and Workplace Safety?

With greater legalization and public approval, the question of safety grows more important.

Read More →
Clinical Insights
Telemedicine Patterns of Use and Reimbursement

A WCRI report explores telemedicine utilization.

Read More →
Industry Trends
Interstate Variation and Trends in Workers’ Comp Drug Payments

WCRI explores how drug payments varied across 28 states for key drug therapy groups.

Read More →
Innovation
New Drug in Development Could Help Patients with Spinal Cord Injuries

AZD1236, currently in Phase 2 trials, has shown an 80% preservation in nerve function following spinal cord injury.

Read More →
Healthe Developments
No “Set It and Forget It” for Pharmacy Trends, and How Automation Can Lend a Helping Hand

Silvia Sacalis and Tate Rice take turns in WorkCompWire’s Leaders Speak Series.

Read More →

June 2022

Medmonitor
Walmart Recalls Supplement for Joint Pain Due to Hidden Drug Ingredients

Artri Ajo King contains undeclared diclofenac, creating safety concerns.

Read More →
This Month's Must Read
Out of Stock: Medical Supply Chain Shortages Impacting Worker’s Comp

Ancillary medical product and service shortages and how to manage them.

Read More →
Clinical Insights
Gabapentin-Involved Overdose Deaths on the Rise

A new report from the CDC found that 10% of overdose deaths in 2019-2020 involved gabapentin.

Read More →
Legislation & Policy
Rhode Island Legalizes Recreational Marijuana

A total of 19 states now allow for recreational marijuana in adults aged 21 and older.

Read More →
Healthe Developments
Why Novel Physical Therapy Strategies are Getting Attention from Workers’ Comp

Risk and Insurance® magazine speaks to industry professionals, including Healthe’s Director of Product Management, Tate Rice.

Read More →

May 2022

Medmonitor
FDA Issues Warning for Consumer Products with Hidden Pain Medications

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.

Read More →
This Month's Must Read
Giving Notice: How Workforce Attrition Impacts Workers’ Comp

Millions of workers are changing occupations, leading to ripple effects for comp.

Read More →
Clinical Insights
IQVIA Reports on Trends and Future Outlook for Drug Utilization and Spend

Spending and utilization are returning to pre-pandemic levels, with biologics growing in prominence.

Read More →
Opioid Developments
FDA Considers Requiring Mail-Back Envelopes for Opioid Prescriptions

The public comment period is underway for this action, which could help with safer drug disposal.

Read More →
Healthe Developments
Silvia Sacalis to Join Panel Presentation at PRIMA 2022

Healthe’s VP of Clinical Services will join a discussion on post-COVID lessons for workers’ comp.

Read More →

April 2022

Medmonitor
Phase 2 Trials for Non-Opioid Pain Medication Deliver Promising Results

VX-548 delivered significant improvements in pain with few adverse events.

Read More →
This Month's Must Read
Out of Balance: Workforce Gender Disparities and What They Mean for Workers’ Comp

Women workers were more adversely impacted by the pandemic and the recession.

Read More →
Marijuana Developments
Positive Marijuana Drug Screenings Reach All Time High

Quest Diagnostics reports increased positivity rates for marijuana in employee drug screenings.

Read More →
COVID-19 Developments
FDA Authorizes Second COVID-19 Booster Dose for Special Populations

Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.

Read More →
Industry Trends
NCCI Reports on Return-to-Work Strategies

Carriers share their thoughts on successful RTW programs.

Read More →

March 2022

Medmonitor
FDA Approves Fleqsuvy for Spasticity

A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.

Read More →
This Month's Must Read
2022 Workers’ Comp Industry Insights Survey Report

Nearly 500 stakeholders share their thoughts on industry challenges and priorities.

Read More →
Opioid Developments
CDC to Update Opioid Guideline

Proposed changes are open to public comment until April 11th.

Read More →
Legislation & Policy
First Responder PTSD Bills Return to the Forefront

After a drop in activity due to the pandemic, five states are now considering legislation.

Read More →
Healthe Developments
Five Things to Know About Workers’ Compensation Pharmacy Services

Healthe’s VP of Industry and State Affairs, Sandy Shtab, joined an educational webinar from IAIABC.

Read More →

February 2022

Medmonitor
FDA Issues Warning for Dental Problems with Dissolvable Buprenorphine Products

Buprenorphine is an opioid used to treat pain, as well as opioid-use disorder.

Read More →
This Month's Must Read
Classification Complications: Will Gig Workers Enter the Workers’ Comp Market?

Legislation could potentially reclassify gig workers as employees entitled to workers’ comp.

Read More →
COVID-19 Developments
FDA Fully Approves Moderna Vaccine & Expands Veklury’s Treatment Range

Drug advancements surrounding the prevention and treatment of COVID-19.

Read More →
Legislation & Policy
Marijuana: States Move Forward Medically and Recreationally, But Oppose Reimbursement in Comp

Since the start of 2022, at least 10 states are considering some form of marijuana legislation.

Read More →
Healthe Developments
Claims Adjusters Are the Future Leaders of Workers’ Comp: How Can We Nurture Their Success?

Healthe’s Director of Product Management talks to Risk & Insurance on how to attract and retain talent in the workers’ comp industry.

Read More →

January 2022

Medmonitor
FDA Approves Yusimry as a Biosimilar to Humira

This autoimmune drug was approved for various arthritic and autoimmune diseases.

Read More →
This Month's Must Read
The Top Priorities of the Workers’ Comp Industry for Future Resiliency

The initial results from a collaborative survey between Healthe and Risk & Insurance.®

Read More →
COVID-19 Developments
Additional Vaccine Candidate Performs Well in Clinical Trials

Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.

Read More →
Clinical Insights
CDC Updates Isolation and Quarantine Period for COVID-19

New five-day rules are recommended, with variation depending upon vaccination status.

Read More →
Industry Trends
The Great Resignation Continues to Impact Workforce Dynamics

The Bureau of Labor Statistics reports that 4.5 million employees quit their jobs in November 2021.

Read More →
Healthe Developments
4 Ways to Manage Medical Supply Chain Disruption in Workers’ Comp

Healthe’s SVP of Product Strategy and Innovation, Kristine Kennedy, discusses this topic with Risk & Insurance magazine.

Read More →

December 2021

Medmonitor
COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

Read More →
This Month's Must Read
The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by the virus may face long-term health complications.

Read More →
1 2 3 6

Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe
Back to Top
lockenvelopephone-handsetcrossmenucross-circle